China medicine and Health Industry Co., Ltd. is a state-owned listed company (stock abbreviation: China medicine; Stock Code: 600056) listed on Shanghai Stock Exchange. Its controlling shareholder is China General Technology (Group) Holding Co., Ltd., a central backbone enterprise. Adhering to the core concept of "caring for life and pursuing excellence", the company is committed to the development of pharmaceutical industry and human health, and strives to build a flagship enterprise in the field of Chinese medicine.
The company has established an industrial pattern of science, industry and trade integration with international trade as the guide, pharmaceutical industry as the support and pharmaceutical commerce as the link. The industrial form involves the whole industrial chain of R & D, planting and processing, production, distribution, logistics, import and export trade, academic promotion and technical services.
In the field of pharmaceutical R & D and production, the company has two postdoctoral scientific research workstations and a large number of high-quality R & D experts, and has won the second prize of national science and Technology Progress Award; the company has domestic leading R & D and production platform of chemical raw materials, domestic advanced R & D and production platform of characteristic chemical drugs and modern Chinese medicine, and is engaged in R & D and production of anti infective and antiviral drugs, as well as liquorice and other medicinal materials In the field of planting and processing products in a leading position.
In the field of international trade, as the main traditional professional channel in the field of import and export of the pharmaceutical industry, the company has always maintained a leading position, and has traditional strength and characteristic advantages in the field of government project business. The natural medicine trade business adheres to the whole industry chain professional development mode, organically integrates natural medicine planting, warehousing, processing, sales and other industrial chain links, and occupies a leading position in the industry. The business scope of pharmaceutical and chemical trade covers chemical raw materials and preparations, biological and blood products, and can provide first-class pharmaceutical and chemical trade integration services for customers. The medical device trade business is committed to providing customers with integrated services in the whole process of the project, and has established a solid cooperative relationship with the world's famous medical device manufacturers, leading in the field of import and distribution in China. The bulk commodity business in the health field involves health food raw materials, bulk agricultural products, fine chemical raw materials, etc., and has a high reputation in the import and export trade of some key commodities.
In the field of domestic pharmaceutical business, the company has gradually established a pharmaceutical business system with high-end and characteristic products as the core and the advantages of industrial value chain integration and collaboration. It has formed a nationwide marketing network system focusing on Beijing, Guangdong, Jiangxi, Henan, Hebei, Hubei and Xinjiang, and has a high reputation and brand influence in the region. The company has a large-scale logistics center, with perfect business qualification, can provide a full range of value-added services for the majority of partners.
Facing the future, sinopharma strives to establish a marketing network across domestic and international markets in key product areas, focus on core industries such as modern traditional Chinese medicine, characteristic chemicals and biopharmaceuticals, build an industrial chain integrating R & D, production, sales and service, and strive to develop the company into a company with an important position in the domestic pharmaceutical industry and in the international market It is a large pharmaceutical enterprise group with strong competitiveness and brand influence.